When Sadness Became a Symptom

There is a specific and telling moment in the history of modern psychology when grief was given a time limit. The DSM-5, published in 2013, removed the bereavement exclusion from major depressive disorder — the provision that had previously prevented clinicians from diagnosing depression in people who were simply grieving a death. After two months, under the revised criteria, sadness that had not resolved could be classified as a clinical disorder. The decision was controversial within the field. Critics pointed out, correctly, that grief does not follow a two-month schedule, and that redefining natural mourning as a disorder changed not just how we talked about grief but what people were offered in response to it — primarily medication. This was not an isolated decision. It was the logical endpoint of a decades-long trend: the progressive reclassification of ordinary human emotional experience as pathology.

The Expansion of the Diagnostic Map

The DSM has grown from 106 diagnoses in its first edition to over 300 in its current one. Some of this reflects genuine scientific progress — the identification of real conditions that were previously missed or misunderstood. But a meaningful portion of that expansion involves the medicalization of experiences that most cultures throughout most of human history classified as normal, if painful, responses to ordinary life. Shyness became social anxiety disorder. Excessive worry became generalized anxiety disorder. Difficulty concentrating became attention deficit disorder. The categories themselves are not false — the suffering they describe is real. But the line between the clinical condition and the ordinary human experience it resembles has become blurry in ways that serve institutional interests more than they serve patients.

Who Benefits

Research from the University of California, San Francisco's pharmaceutical policy program found that diagnostic expansion in psychiatry has closely tracked the marketing interests of pharmaceutical manufacturers — not because researchers are corrupt, but because industry funding shapes research questions, which shapes what gets named and measured, which shapes what gets treated. The mapping of human suffering onto pharmacological targets is not a neutral scientific process. This does not mean that psychiatric medication is never appropriate. For many people it is genuinely useful, sometimes life-saving. The problem is not that the medications exist. The problem is that when the diagnostic category expands to include ordinary emotional experience, the medication gets offered to people who might benefit more from structural change, rest, human connection, or simply permission to feel what they feel without it being a disorder.

The Social Function of Emotional Suppression

Here is the part of this conversation that usually gets left out: the pathologizing of difficult emotions is not only a medical phenomenon. It is also a workplace phenomenon, a productivity phenomenon, and a social control phenomenon. An employee who names their exhaustion as burnout that requires structural change is more disruptive to an organization than one who understands their exhaustion as a personal anxiety disorder requiring individual treatment. Medicalization, in this sense, is efficiency-serving. It routes suffering into private channels — the therapist's office, the prescription — rather than collective ones. A 2021 analysis from researchers at Cambridge University examining occupational health policy found that organizations with strong individual-focused mental health programming showed no improvement in workforce wellbeing outcomes, while organizations that reduced workload demands and increased schedule autonomy showed significant improvement. The individualized approach to emotional distress was not just inadequate — it functioned as a substitute for the structural changes that would have actually helped.

The Tangent That Cuts to the Center

Many of the emotions being pathologized are not problems to be solved but information to be used. Anxiety about an unsafe situation is appropriate and adaptive. Grief after a significant loss is biologically necessary and serves social bonding functions. Anger at injustice is motivationally crucial. The therapeutic project of returning people to emotional equilibrium is sometimes helpful and sometimes a project of returning them to compliance.

What Progress Would Actually Look Like

Progress would mean developing a much finer-grained public understanding of when emotional distress signals something that needs clinical attention and when it signals something that needs to change in the world. It would mean taking seriously the difference between pathology and pain. Pain is not always a disorder. Sometimes it is the correct response to a situation that is genuinely painful. Calling it a disorder does not make it stop hurting. It just changes who is held responsible for making it stop.